Harnessing Engineered iPSC-Derived Immuno-Modulatory Alpha Neutrophils for Immune Reconstitution & Cancer Therapy
Time: 2:00 pm
day: Day One Track A Afternoon
Details:
- Exploring the potential of iPSC-derived alpha neutrophils to restore immune function in oncology and age-related diseases
- Strategies to leverage these cells for robust immune reconstitution following immunosuppressive treatments
- Evaluating therapeutic applications across cancer and chronic inflammation driven by immune decline with age
